New Hepatitis C vaccine design developed at the University of Lübeck (IMAGE)
Caption
Dr. Kumar Nagarathinam, lead author of the pioneering study, presents the innovative vaccine design targeting the Hepatitis C virus (HCV). Conducted at the Institute of Virology at the University of Lübeck under the guidance of Prof. Dr. Thomas Krey, this research was published in the renowned journal Science Advances and represents a significant milestone in vaccine development.
Credit
Picture was taken by Dinesh Thiyagaraj
Usage Restrictions
May be used if the author is acknowledged
License
Original content